Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Letter in Reply titled “Cost-effectiveness of Nusinersen for Spinal Muscular Atrophy,”1 published online on May 7, 2018, no conflicts of interest were disclosed. The Conflict of Interest Disclosures should have been “Dr Prasad reports receiving royalties from his book Ending Medical Reversal; that his work is funded by the Laura and John Arnold Foundation; that he has received honoraria for Grand Rounds/lectures from several universities, medical centers, and professional societies; and that he is not compensated for his work at the Veterans Affairs Medical Center in Portland, Oregon, or the Health Technology Assessment Subcommittee of the Oregon Health Authority.” This article was corrected online.
Missing Potential Conflict of Interest. JAMA Pediatr. 2018;172(9):891. doi:10.1001/jamapediatrics.2018.2494
Create a personal account or sign in to: